Bill

BILL • US HOUSE

HCONRES 35

Exposing Congressional Drug Abuse Act

119th Congress
Introduced by Clay Higgins,

The Exposing Congressional Drug Abuse Act calls for investigating drug abuse among Congress members, promoting transparency, accountability, and support for affected individuals.

Submitted in House
0
0
Bill Summary • HCONRES 35

Summary of HCONRES 35: Exposing Congressional Drug Abuse Act

Purpose and Intent

The Exposing Congressional Drug Abuse Act (HCONRES 35) aims to address and bring to light issues related to drug abuse within Congress. The resolution seeks to promote transparency and accountability regarding substance abuse among members of Congress, emphasizing the need for a comprehensive examination of the issue.

Key Provisions

While the specific text of the resolution is not provided, the following key provisions can be inferred based on the title and legislative intent:

  • Investigation of Drug Abuse: The resolution likely calls for an investigation into allegations of drug abuse among congressional members, aiming to gather data and testimonies to better understand the prevalence and impact of substance abuse in legislative environments.

  • Reporting Requirements: It may establish requirements for reporting findings to ensure that the results of the investigation are made public, thereby fostering accountability.

  • Recommendations for Action: The resolution could propose recommendations for addressing drug abuse, which may include support programs for affected members, educational initiatives, or policy changes to mitigate the issue.

Affected Parties

The primary parties affected by this resolution include:

  • Members of Congress: The resolution directly targets congressional members, aiming to address any issues of drug abuse within this group.

  • Congressional Staff: Staff members may also be indirectly affected, as the resolution could lead to changes in workplace policies and support systems.

  • Public and Advocacy Groups: The resolution may engage public interest groups and advocacy organizations focused on drug abuse prevention and treatment, as they may play a role in the proposed investigations or subsequent actions.

Procedural Aspects

  • Introduced Date: The resolution was introduced on June 5, 2025.

  • Legislative Actions:

    • On the same day of its introduction, it was referred to the House Committee on House Administration for further consideration.
  • Current Status: As of now, the resolution is in the early stages of the legislative process, having just been submitted and referred to committee.

Conclusion

HCONRES 35 represents a significant step toward addressing drug abuse within Congress, aiming to enhance transparency and accountability. By investigating this issue, the resolution seeks to foster a healthier legislative environment and promote the well-being of its members. Further developments will depend on the actions taken by the House Committee and subsequent legislative processes.

Hi! I'm your AI assistant for HCONRES 35. I can help you understand its provisions, impacts, and answer any questions.

Key Provisions Impacts Timeline
Sign in to chat